ERN1 and Miyoshi myopathy: A study unveiled that the small molecule inhibitor of IRE1, STF-083010, exhibited significant antimyeloma activity in simulated human multiple myeloma (MM) xenografts, inhibiting IRE1 endonuclease activity both in vitro and in vivo(Papandreou et al. 2011).